IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 21,200
+1,280 (6.43%)
At close: Aug 11, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 318.47 billion as of August 12, 2026. Its market cap has decreased by -14.89% in one year.
Market Cap
318.47B
Enterprise Value
301.26B
Revenue
2.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
21,200.00
ChartMarket Cap Chart
Since May 23, 2025, IntoCell's market cap has decreased from 492.33B to 318.47B, a decrease of -35.31%. That is a compound annual growth rate of -30.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 318.47B | -63.01% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 416.24B |
| Curocell | 410.37B |
| HansBiomed | 308.76B |
| IMBiologics | 271.21B |
| S.Biomedics | 239.03B |
| Kangstem Biotech | 224.79B |
| curacle co.,ltd. | 210.91B |
| Kanaph Therapeutics | 185.00B |